Gufic BioSciences Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹251.82 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.82 per cent from ₹231.41 crore. This corresponds to a year-on-year *(YoY) growth of 22.83 per cent.
Operating Profit
Operating Profit stands at ₹47.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 43.15 per cent from ₹32.98 crore. This corresponds to a year-on-year *(YoY) growth of 79.03 per cent.
PBDT
PBDT stands at ₹36.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.04 per cent from ₹25.41 crore. This corresponds to a year-on-year *(YoY) growth of 99.35 per cent.
Profit Before Tax
Profit Before Tax stands at ₹28.95 crore, reflecting a quarter-on-quarter *(QoQ) increase of 63.37 per cent from ₹17.72 crore. This corresponds to a year-on-year *(YoY) growth of 175.19 per cent.
Net Profit
Net Profit stands at ₹21.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 76.33 per cent from ₹12.42 crore. This represents a 183.68 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Gufic BioSciences Ltd Earnings
- YOY
- QOQ
Gufic BioSciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gufic BioSciences Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Gufic BioSciences Ltd Financial Reports
Gufic BioSciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gufic BioScience | 1.90% | 0.61% | 3.83% | 33.20% | 25.15% | 2.33% |
| RPG LifeScience. | -0.10% | -3.96% | 14.36% | 14.17% | 40.81% | 17.46% |
| IOL Chemicals | 1.39% | -0.54% | 1.25% | 53.99% | 89.01% | 43.61% |
| Guj. Themis Bio. | 2.02% | 0.84% | -6.84% | -3.78% | 7.47% | -3.70% |
| Aarti Drugs | 2.34% | 3.99% | 11.58% | 7.24% | 14.40% | -14.09% |
| Novartis India | -1.82% | -2.19% | 5.85% | 51.12% | 86.64% | 59.25% |
| Unichem Labs. | -1.43% | -3.85% | 10.73% | 33.28% | 23.03% | -8.22% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Jayesh P Choksi
ED / WTD / CEO / Promoter : Pranav J Choksi
Whole-time Director : Pankaj Gandhi
Independent Non Exe. Director : Anusanjiv Aurora
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Akshya Kumar Mahapatra
Company Sec. & Compli. Officer : Ami Naresh Shah